Ever Fortune.AI Co., Ltd.

6841

TW0006841000

IT Services & Consulting

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
86.7 ^TWD	-0.46%		+2.24%	-10.16%

Apr. 09	Ever FEver Fortune.AI Co., Ltd. Announces U.S.FDA Approves EFAI Cardiosuite CTA AcuteAortic Syndrome Assessment System (EFAI AASCTA)	CI
Apr. 01	Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Ever Fortune.AI Co., Ltd.(TPEX:6841) added to S&P Global BMI Index

March 21, 2022 at 12:00 am EDT

Latest news about Ever Fortune.AI Co., Ltd.

Ever FEver Fortune.AI Co., Ltd. Announces U.S.FDA Approves EFAI Cardiosuite CTA AcuteAortic Syndrome Assessment System (EFAI AASCTA)	Apr. 09	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 31	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-14	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-24	CI
Ever Fortune.AI Co., Ltd.(TPEX:6841) added to S&P Global BMI Index	22-03-21	CI

Chart Ever Fortune.AI Co., Ltd.

Duration

Period

More charts

Ever Fortune. AI Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of medical artificial intelligence software related products. The Company mainly provides medical big data and cloud biomedical platform, medical artificial intelligence (AI) technology solutions. The Company provides medical artificial intelligence data, analysis technology and services, and customized medical AI technology solutions. The Company's products include radiographic bone age-assisted interpretation and height prediction system, ultrasound breast tumor auxiliary classification system, computer tomography liver cancer metastasis risk management system, liver fibrosis evaluation system, and irregular cardiac fibrillation interpretation.

Sector

IT Services & Consulting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

86.7 TWD

Average target price

130 TWD

Spread / Average Target

+49.94%

Consensus

Sector Other IT Services & Consulting

	1st Jan change	Capi.
EVER FORTUNE.AI CO., LTD.	-10.16%	258M
ACCENTURE PLC	-13.02%	194B
TATA CONSULTANCY SERVICES LTD.	+2.02%	166B
IBM	+2.10%	153B
AUTOMATIC DATA PROCESSING, INC.	+4.57%	99.85B
RELX PLC	+6.08%	77.56B
CROWDSTRIKE HOLDINGS, INC.	+19.99%	73.55B
INFOSYS LIMITED	-7.01%	71B
SNOWFLAKE INC.	-20.33%	52.81B
HCL TECHNOLOGIES LIMITED	-5.37%	47.86B

Other IT Services & Consulting